Tonix Pharmaceuticals Holding Corp
TNXP
Get informed when a big investor buys or sells
+ FollowMarket Cap$191.77M
Close$
$12.45
0.4% downside
Current Fair Value
0.4% downsideOvervalued by 0.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $191.77 Million |
|---|---|
| Enterprise Value | $20.62 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-14.57 |
| Beta | 1.65 |
| Outstanding Shares | 13,707,104 |
Return
| Return on Equity | -50.73% |
|---|---|
| Return on Assets | -44.38% |
| Return on Invested Capital | -72.72% |
Valuation & Multiples
| P/E Ratio | -0.82 |
|---|---|
| PEG | - |
| Price to Sales | 6.25 |
| Price to Book Ratio | 0.78 |
| Enterprise Value to Revenue | 0.71 |
| Enterprise Value to EBIT | -0.13 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.25 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
$-2.64
Average shareholder expectationRevenue Estimate
$7.72 M
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-2.48
Average shareholder expectationRevenue Estimate
$14.15 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 75.66% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 15.12%▼ 20.40% |
|---|---|
| Total Invested | $26.45M▼ 60.51% |
| Investors Holding | 32▼ 55.00% |
ESG Score
No data
About Tonix Pharmaceuticals Holding Corp
CEO: Seth Lederman